Bottom line
How much do FHLC and SCHLX overlap?
81% of their top holdings overlap by weight. 21 securities appear in both funds' top 25, making up 67.7% of FHLC's assets and 69.3% of SCHLX's. They are largely the same portfolio — owning both adds little diversification.
FHLC holds far more positions (337 vs 65), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings FHLC and SCHLX have in common
| Holding | % of FHLC | % of SCHLX | Overlap |
|---|---|---|---|
| Eli Lilly & Co | 13.35% | 13.85% | 13.35% |
| Johnson & Johnson | 8.93% | 6.19% | 6.19% |
| AbbVie Inc | 6.42% | 4.90% | 4.90% |
| UnitedHealth Group Inc | 5.44% | 5.73% | 5.44% |
| Merck & Co Inc | 4.66% | 4.85% | 4.66% |
| Thermo Fisher Scientific Inc | 3.09% | 3.46% | 3.09% |
| Amgen Inc | 3.00% | 2.88% | 2.88% |
| Abbott Laboratories | 2.66% | 2.39% | 2.39% |
| Gilead Sciences Inc | 2.34% | 2.78% | 2.34% |
| Pfizer Inc | 2.06% | 1.17% | 1.17% |
| Bristol-Myers Squibb Co | 1.93% | 1.50% | 1.50% |
| Intuitive Surgical Inc | 1.82% | 2.69% | 1.82% |
| Danaher Corp | 1.80% | 2.13% | 1.80% |
| Vertex Pharmaceuticals Inc | 1.76% | 2.45% | 1.76% |
| Stryker Corp | 1.62% | 2.61% | 1.62% |
| Medtronic PLC | 1.59% | 1.54% | 1.54% |
| McKesson Corp | 1.52% | 2.05% | 1.52% |
| Regeneron Pharmaceuticals Inc | 1.15% | 1.43% | 1.15% |
| Boston Scientific Corp | 1.00% | 2.10% | 1.00% |
| Cencora Inc | 0.83% | 1.26% | 0.83% |
| Cardinal Health Inc | 0.78% | 1.34% | 0.78% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in FHLC
- CVS Health Corp — 1.92%
- Elevance Health Inc — 1.19%
- Cigna Group/The — 1.06%
- HCA Healthcare Inc — 0.91%
Only in SCHLX
- AstraZeneca PLC — 3.80%
- Novartis AG — 2.90%
- Novo Nordisk A/S — 1.73%
- Roche Holding AG — 1.24%
Asset mix
| Asset type | FHLC | SCHLX |
|---|---|---|
| Stocks | 99.7% | 99.6% |
| Cash & short-term funds | 0.2% | 0.5% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)
Country mix
| Country | FHLC | SCHLX |
|---|---|---|
| US | 96.5% | 85.7% |
| CH | 0.1% | 5.2% |
| GB | 0.5% | 3.8% |
| IE | 2.2% | 1.5% |
| DK | — | 1.7% |
| NL | 0.1% | 1.0% |
| FR | — | 1.0% |
| BM | 0.2% | — |
Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)
Check another pair
FAQ
How much do FHLC and SCHLX overlap?
What stocks do FHLC and SCHLX have in common?
Should I own both FHLC and SCHLX?
Which holds more stocks, FHLC or SCHLX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.